Proton beam centres ‘to treat 1,500 patients a year’ – BBC News

Two new NHS proton beam therapy facilities could offer treatment to 1,500 cancer patients a year when they open in the next few years. The therapy – which is particularly helpful for children with rare and complex tumours – was highlighted with the case of Ashya King last year. The five-year old’s parents took him abroad […]

Health Service Journal – Only together can we beat cancer

Collaboration between public and private organisations is vital if the NHS is to win the war on cancer, says Sanjeev Pandya, CEO of Advanced Oncotherapy (AVO). The government’s latest strategy to improve cancer treatment in the UK is welcome, but extra funding alone is not the answer. Greater collaboration is the key to winning the […]

Advanced Oncotherapy – US cancer treatment centre targets China for proton therapy

US cancer treatment centre targets China for proton therapy In its efforts to attract more international cancer patients to Jacksonville, the University of Florida Health Proton Therapy Institute has held its first-ever symposium in China. Representatives for the institute had a two-week visit to China where they met with health care providers to talk about […]

We Can Fight Cancer

Dr Tejinder Kataria (Chairperson – Medanta Cancer Institute) Cancer is a disease that can affect any part of the body and manifests with symptoms pertaining to the organ / system it affects. Cancer is a non communicable disease and is responsible for a higher mortality than heart disease in the western world. As the developing […]

Global proton therapy market will hit $1 billion by 2019

by Lauren Dubinsky , Staff Writer at DOTmed.com In 2014, there were 141 operational proton therapy treatment rooms globally, but by 2019 that number will jump to 330, according to a new MEDraysintell report. In addition, the proton therapy world market is expected to hit $1 billion by 2019. “There is a growing [amount] of […]

Feedback announces a new drug trial and provides a trading update

Feedback plc notes that TexRAD, its texture analysis software product will be used by Imaging Endpoints II, LLC, its exclusive partner, for imaging core lab purposes in a forthcoming drug trial in the United States. A study will shortly be commenced of colorectal cancer patients (Stage IIIc) with either Regorafenib or Standard of Care (No […]